22nd European Pharma and Biotech Project, Program and Portfolio Management Conference - Spring Edition

2-Day Conference

Annual Project, Program, and Portfolio Management Conference in Pharma & Biotech with a focus on
New Ways of Working.

KEY TOPICS

EVENT FEATURES

LEARNING

Hear from 30 speakers across 28 case-studies, panel discussions, workshop sessions, and keynote presentations to find industry trends, benchmark your work, and learn new strategies

INNOVATION

Find real approaches to new ways of working. Learn about how key innovations (Machine Learning, Artificial Intelligence) are changing the ways we do Project & Portfolio and see how you could apply them.

NETWORKING

Explore the event's in-person networking features to meet industry peers, share challenges, discuss opportunities, and find new approaches.

2023 EVENT SPEAKERS

Bence Tüske

Head of Program Management Office at Sanofi

Irena Prasilova

Director - CTO Office Strategy and Operations at Merck Sharp & Dohme

Denise Moody

Chief Operating Officer at Kuano

Jeremy Cooper

MD, Performance Coach, Head of IT at Balanced Life

Bence Kovacs

Senior Director, Global Oncology Strategy at GSK

Sarah Cahill

Associate Director – Enterprise Cell & Gene Therapy Alliance Management at Labcorp Drug Development

Klemen Spaninger

Head of PMO Biotechnology at Gedeon Richter

Stephane Royer

Global Procurement Senior Manager at Ferring Pharmaceuticals

Philip Van Der Veen

Director, Prospect and Program Management at Theradex Oncology

Rosa Arienzo

Senior Project Manager at LifeArc

Estelle Bernard-Fichet

Senior Project Manager at bit.bio

Jörn Lenz

Senior Global Portfolio & Database Manager at medac GmbH

Sarah Hudson

Senior Director, Program and Alliance Manager at Avidity Biosciences

Loïc Vandermeeren

Head of Information Technology, Senior Director at Covis Pharma

Mirjam Foti

Director Program Management Office at Pharming Group

Johan Verboven

Associate Director, PMO Governance & Portfolio at UCB

Ailsa Mendez

Executive Director, Biotech Portfolio Lead at PPD
Show More Speakers

From our previous events

Testimonials

AGENDA

VIEW ALL SESSIONS & THEIR DESCRIPTIONS

REGISTRATION

Conference

Ticket | April 19-20, 2023
£ 2099
  • Access to All 22nd European Pharma and Biotech Project, Program and Portfolio Management Conference - Spring Edition
  • Access to Post Conferences Networking
  • Conference Materials
  • Includes Coffee Breaks, Snacks and Refreshments, Seated Lunch

Masterclass

Ticket | April 17-18, 2023
£ 2199
  • Access to Project, Program, and Portfolio Risk Analysis Masterclass with Industry Veteran Dr. Richard Bayney.
  • Individual consultancy with the trainer
  • Colored hardcopy of training materials in a binder
  • Electronic copy of trainer's textbook
  • Certificate of completion issued by the trainer

Masterclass + Conference

Ticket | April 17-20, 2023
£ 3199
  • Grants all Masterclass and Conference Ticket Benefits including access to the Project, Program, and Portfolio Risk Analysis Masterclass + European Pharma & Biotech PPM Conference, London, at a special rate.
SAVE £1099

BECOME A PARTNER

OF this EVENT
  • Present on the Main Stage
  • Hold an exhibit at this event
  • Showcase your Brand in Marketing Material
  • Gain exposure through alternative partnership benefits

event partners

Planisware is a global provider of software solutions for project portfolio management. Planisware solutions are specifically designed to support product development, engineering and IT business processes. For more than 20 years, Planisware has been helping its customers to achieve strategic and innovative excellence, make valid business decisions and increase portfolio value. Today, over 500 companies worldwide rely on Planisware products to manage their projects, resources and portfolios.

Intelligencia uses Artificial Intelligence to de-risk drug development. Our platform focuses on estimating the risk of clinical trials, and interpreting the multitude of factors that contribute to that risk. We therefore aim to bridge the gap between innovation and risk reduction, with the ultimate goal of bringing novel therapies to patients faster. Our interdisciplinary team of software engineers, AI practitioners, scientists, and drug developers brings together and interprets disparate data across the life sciences industry.

Our platform offers a suite of functionalities that provide unprecedented data clarity and Machine-Learning fueled predictions to enable critical decision making. We currently work with several of the largest global pharmaceutical companies, as well as with mid-size and smaller biotechnology companies. Diseases will impact nearly every individual. At Intelligencia, we work to make a difference.

AGENDA DOWNLOAD